Home > Ross Enterprise > Resources
Description:
Many life sciences companies are struggling to manage large group purchase organization (GPO) contracts, process heavy volumes of chargeback submissions and ensure pricing policies are fully compliant with regulatory requirements. As the complexity of GPO contracts and expectations of large wholesalers grow, life sciences companies run the risk of lost market share and massive revenue leakage. According to IDC Research, manufacturers lose 4-5% of revenue annually due to inefficiencies in the reconciliation process.
At present, many life sciences companies rely on manual systems to handle contracts and chargebacks. These approaches tend to be inaccurate, inefficient and labor intensive. As sales volumes increase, they threaten to undermine operational effectiveness and corporate profitability.
Fortunately, there are smart and cost-effective solutions that match the needs of today’s dynamic and growth-focused pharmaceutical manufacturers. Read "The Executive Guide to Contract and Chargeback Management" to learn how you can eliminate chargeback processing errors, ensure compliance, and strengthen profitability by automating your contracts and chargebacks process.
Please complete the registration form below for this white paper.